NM_001039141.3:c.5767G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001039141.3(TRIOBP):​c.5767G>A​(p.Ala1923Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000512 in 1,585,030 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1923E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00065 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00050 ( 6 hom. )

Consequence

TRIOBP
NM_001039141.3 missense

Scores

19

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.261

Publications

7 publications found
Variant links:
Genes affected
TRIOBP (HGNC:17009): (TRIO and F-actin binding protein) This gene encodes a protein with an N-terminal pleckstrin homology domain and a C-terminal coiled-coil region. The protein interacts with trio, which is involved with neural tissue development and controlling actin cytoskeleton organization, cell motility and cell growth. The protein also associates with F-actin and stabilizes F-actin structures. Mutations in this gene have been associated with a form of autosomal recessive nonsyndromic deafness. Multiple alternatively spliced transcript variants that would encode different isoforms have been found for this gene, however some transcripts may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Nov 2008]
TRIOBP Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 28
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005015224).
BP6
Variant 22-37757692-G-A is Benign according to our data. Variant chr22-37757692-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 178559.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000498 (713/1432700) while in subpopulation MID AF = 0.00523 (30/5736). AF 95% confidence interval is 0.00376. There are 6 homozygotes in GnomAdExome4. There are 423 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRIOBPNM_001039141.3 linkc.5767G>A p.Ala1923Thr missense_variant Exon 16 of 24 ENST00000644935.1 NP_001034230.1 Q9H2D6-1
TRIOBPNM_007032.5 linkc.628G>A p.Ala210Thr missense_variant Exon 6 of 14 NP_008963.3 Q9H2D6-7
TRIOBPNM_138632.2 linkc.628G>A p.Ala210Thr missense_variant Exon 6 of 8 NP_619538.2 Q9H2D6-6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRIOBPENST00000644935.1 linkc.5767G>A p.Ala1923Thr missense_variant Exon 16 of 24 NM_001039141.3 ENSP00000496394.1 Q9H2D6-1

Frequencies

GnomAD3 genomes
AF:
0.000650
AC:
99
AN:
152212
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00835
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000662
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000915
AC:
179
AN:
195726
AF XY:
0.000981
show subpopulations
Gnomad AFR exome
AF:
0.000175
Gnomad AMR exome
AF:
0.000447
Gnomad ASJ exome
AF:
0.00839
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000616
Gnomad NFE exome
AF:
0.000534
Gnomad OTH exome
AF:
0.00198
GnomAD4 exome
AF:
0.000498
AC:
713
AN:
1432700
Hom.:
6
Cov.:
32
AF XY:
0.000596
AC XY:
423
AN XY:
710128
show subpopulations
African (AFR)
AF:
0.0000304
AC:
1
AN:
32870
American (AMR)
AF:
0.000446
AC:
18
AN:
40328
Ashkenazi Jewish (ASJ)
AF:
0.00799
AC:
204
AN:
25540
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38164
South Asian (SAS)
AF:
0.00117
AC:
96
AN:
82306
European-Finnish (FIN)
AF:
0.0000202
AC:
1
AN:
49524
Middle Eastern (MID)
AF:
0.00523
AC:
30
AN:
5736
European-Non Finnish (NFE)
AF:
0.000268
AC:
294
AN:
1098922
Other (OTH)
AF:
0.00116
AC:
69
AN:
59310
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
47
94
140
187
234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000650
AC:
99
AN:
152330
Hom.:
0
Cov.:
32
AF XY:
0.000483
AC XY:
36
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41582
American (AMR)
AF:
0.000915
AC:
14
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00835
AC:
29
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000662
AC:
45
AN:
68006
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000839
Hom.:
0
Bravo
AF:
0.000722
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000816
AC:
7
ExAC
AF:
0.000550
AC:
66
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TRIOBP: BP4, BS2 -

Oct 06, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 29197352, 28089734, 26969326) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jul 06, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ala1923Thr in exon 16 of TRIOBP: This variant is not expected to have clinica l significance because it has been identified in 0.8% (75/9030) of Ashkenazi Jew ish chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadi nstitute.org; dbSNP rs150947392). In addition, it is not conserved across specie s, including mammals. Of note, bushbaby, mouse, rat, kangaroo rat, and sloth hav e a threonine (Thr) at this position despite high nearby amino acid conservation . -

TRIOBP-related disorder Benign:1
Sep 11, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Autosomal recessive nonsyndromic hearing loss 28 Benign:1
Jul 15, 2020
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
8.1
DANN
Benign
0.86
DEOGEN2
Benign
0.011
T;T;.;.;.;T;T
Eigen
Benign
-0.99
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.20
N
LIST_S2
Benign
0.69
.;T;.;T;T;T;T
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.0050
T;T;T;T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.69
N;N;.;.;.;.;.
PhyloP100
0.26
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.38
N;.;N;N;.;N;N
REVEL
Benign
0.016
Sift
Benign
0.62
T;.;T;T;.;T;T
Sift4G
Benign
0.58
T;.;T;T;.;T;T
Polyphen
0.0050
B;B;.;.;.;.;.
Vest4
0.056
MVP
0.23
MPC
0.11
ClinPred
0.00038
T
GERP RS
-3.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.020
gMVP
0.14
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150947392; hg19: chr22-38153699; API